These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 20352408

  • 21. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.
    Cryer PE.
    Diabetes Care; 2007 Jan; 30(1):190-2; author reply 194-6. PubMed ID: 17192371
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.
    Nathan DM, Buse JB, Davidson MB, Heine RJ, Holman RR, Sherwin R, Zinman B, Professional Practice Committee, American Diabetes Association, European Association for the Study of Diabetes.
    Diabetologia; 2006 Aug; 49(8):1711-21. PubMed ID: 16802130
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Guideline recommendations and the positioning of newer drugs in type 2 diabetes care.
    Marx N, Davies MJ, Grant PJ, Mathieu C, Petrie JR, Cosentino F, Buse JB.
    Lancet Diabetes Endocrinol; 2021 Jan; 9(1):46-52. PubMed ID: 33159841
    [Abstract] [Full Text] [Related]

  • 28. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
    Krentz AJ, Bailey CJ.
    Drugs; 2005 Jan; 65(3):385-411. PubMed ID: 15669880
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. 2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
    Buse JB, Wexler DJ, Tsapas A, Rossing P, Mingrone G, Mathieu C, D'Alessio DA, Davies MJ.
    Diabetologia; 2020 Feb; 63(2):221-228. PubMed ID: 31853556
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. A decision support tool for appropriate glucose-lowering therapy in patients with type 2 diabetes.
    Ampudia-Blasco FJ, Benhamou PY, Charpentier G, Consoli A, Diamant M, Gallwitz B, Khunti K, Mathieu C, Ridderstråle M, Seufert J, Tack C, Vilsbøll T, Phan TM, Stoevelaar H.
    Diabetes Technol Ther; 2015 Mar; 17(3):194-202. PubMed ID: 25347226
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes: response to Nathan et al.
    Jellinger PS, Lebovitz HE, Davidson JA, ACE/AACE Outpatient Glycemic Control Implementation Task Force.
    Diabetes Care; 2007 Apr; 30(4):e16-7; author reply e18-20, e21-2. PubMed ID: 17392531
    [No Abstract] [Full Text] [Related]

  • 35. Novel approaches to the treatment of hyperglycaemia in type 2 diabetes mellitus.
    Galligan A, Greenaway TM.
    Intern Med J; 2016 May; 46(5):540-9. PubMed ID: 27170238
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
    Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, Peters AL, Tsapas A, Wender R, Matthews DR, American Diabetes Association (ADA), European Association for the Study of Diabetes (EASD).
    Diabetes Care; 2012 Jun; 35(6):1364-79. PubMed ID: 22517736
    [No Abstract] [Full Text] [Related]

  • 38. Options for combination therapy in type 2 diabetes: comparison of the ADA/EASD position statement and AACE/ACE algorithm.
    Bailey T.
    Am J Med; 2013 Sep; 126(9 Suppl 1):S10-20. PubMed ID: 23953074
    [Abstract] [Full Text] [Related]

  • 39. Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
    Davies MJ, Aroda VR, Collins BS, Gabbay RA, Green J, Maruthur NM, Rosas SE, Del Prato S, Mathieu C, Mingrone G, Rossing P, Tankova T, Tsapas A, Buse JB.
    Diabetologia; 2022 Dec; 65(12):1925-1966. PubMed ID: 36151309
    [Abstract] [Full Text] [Related]

  • 40. Current medical treatment of diabetes type 2 and long term morbidity: how to balance efficacy and safety?
    Carrera Boada CA, Martínez-Moreno JM.
    Nutr Hosp; 2013 Mar; 28 Suppl 2():3-13. PubMed ID: 23834040
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.